Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations.
Distinguishing tumor DNA from aging-related mutations in blood may help doctors better understand individual cancer risk.
This PubMed record reports circulating tumor DNA (ctDNA) and clonal hematopoiesis of indeterminate potential (CHIP) are two biologically distinct sources of somatic mutations detectable in blood. The study was classified as observational study and is relevant to early detection.
What the study was
- Study design
- Observational study
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Bioinformatics (Oxford, England)
Why it surfaced
Conservative triage based on the PubMed abstract, observational study, clinical relevance, and unmet-need signals.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.